Home Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research
 

Keywords :   


Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research

2016-01-18 00:05:01| Biotech - Topix.net

The firm set a "buy" rating and a $130.00 price target on the biopharmaceutical company's stock. Standpoint Research's price target points to a potential upside of 26.14% from the stock's previous close.

Tags: research coverage receives analysts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.06Global Green Building Alliance Launches Guide to Net Zero
28.06UK economy grew more than first estimated in early 2024
28.06K-pop agents charged with insider trading over BTS
28.06K-pop agents charged with insider trading over BTS
28.06Atlantic Tropical Weather Outlook
28.06Eastern North Pacific Tropical Weather Outlook
28.06USDA moves to change livestock competition rules
28.06Nike tumbles as upstarts grab market share
More »